Archer Investment Corporation’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.5K | Hold |
536
| – | – | 0.01% | 513 |
|
|
2025
Q1 | $39.4K | Buy |
536
+60
| +13% | +$4.41K | 0.01% | 491 |
|
|
2024
Q4 | $31.2K | Hold |
476
| – | – | 0.01% | 511 |
|
|
2024
Q3 | $37.1K | Buy |
476
+2
| +0.4% | +$156 | 0.01% | 480 |
|
|
2024
Q2 | $37K | Hold |
474
| – | – | 0.01% | 462 |
|
|
2024
Q1 | $32.1K | Hold |
474
| – | – | 0.01% | 466 |
|
|
2023
Q4 | $31.9K | Hold |
474
| – | – | 0.01% | 463 |
|
|
2023
Q3 | $32.1K | Hold |
474
| – | – | 0.01% | 442 |
|
|
2023
Q2 | $33.9K | Buy |
474
+274
| +137% | +$19.6K | 0.01% | 432 |
|
|
2023
Q1 | $13.9K | Hold |
200
| – | – | 0.01% | 529 |
|
|
2022
Q4 | $13.6K | Hold |
200
| – | – | 0.01% | 511 |
|
|
2022
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 515 |
|
|
2022
Q2 | $13.2K | Hold |
200
| – | – | 0.01% | 508 |
|
|
2022
Q1 | $14.1K | Hold |
200
| – | – | 0.01% | 509 |
|
|
2021
Q4 | $11.7K | Hold |
200
| – | – | ﹤0.01% | 534 |
|
|
2021
Q3 | $12K | Hold |
200
| – | – | ﹤0.01% | 508 |
|
|
2021
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 442 |
|
|
2021
Q1 | $9.94K | Hold |
200
| – | – | ﹤0.01% | 544 |
|
|
2020
Q4 | $10K | Hold |
200
| – | – | ﹤0.01% | 499 |
|
|
2020
Q3 | $11K | Hold |
200
| – | – | 0.01% | 440 |
|
|
2020
Q2 | $10.6K | Sell |
200
-30
| -13% | -$1.59K | 0.01% | 423 |
|
|
2020
Q1 | $10K | Hold |
230
| – | – | 0.01% | 412 |
|
|
2019
Q4 | $11K | Buy |
230
+200
| +667% | +$9.57K | 0.01% | 439 |
|
|
2019
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 467 |
|
|
2019
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 456 |
|
|
2019
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 466 |
|
|
2018
Q4 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 433 |
|